EmsanaRx, the upstart pharmacy benefit manager (PBM) that says its priority is public health, announced yesterday that it is changing its name to AffirmedRx.
EmsanaRx was launched in late 2021 as project of Emsana Health, an independent company established by The Purchaser Business Group on Health, a coalition of large employers. Emsana Health bills itself as an “innovation studio” for healthcare.
According to a press release Emsana Health sold its equity stake back EmsanaRx.
The press release says that AffirmedRx will continue EmsanaRx’s work “to create a completely unconflicted pharmacy benefit manager that all large self-funded employers can be proud to collaborate with.”
Greg Baker, CEO of EmsanaRx, is staying CEO of AffirmedRx, which has adopted “patients over profits” as it tagline. Like EmsanaRx, AffirmedRex is a public benefit corporation, a legal status that allows the company to prioritize public good and not just shareholders.
Baker says in the new name reflects “our commitment to forging new paths with members to deliver innovation and flexibility.”
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Positive Pipeline Updates for Friedreich’s Ataxia
October 24th 2024After experiencing setbacks, PTC reported positive results for vatiquinone, its selective inhibitor of 15-Lipoxygenase (15-LO) enzyme, regulator of the energetic and oxidative stress pathways that are disrupted in Friedreich ataxia
Read More